Xenon Pharmaceuticals Inc. 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 19, 2015
Insider Transaction Report
Form 4
COHEN CHARLES J.
VP, Biology
Transactions
- Award
Stock Option (Right to Buy)
2015-03-17+35,000→ 35,000 totalExercise: $17.76Exp: 2025-03-16→ Common Shares (35,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2016, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.